CA2524990A1 - Oral skin supplement - Google Patents
Oral skin supplement Download PDFInfo
- Publication number
- CA2524990A1 CA2524990A1 CA002524990A CA2524990A CA2524990A1 CA 2524990 A1 CA2524990 A1 CA 2524990A1 CA 002524990 A CA002524990 A CA 002524990A CA 2524990 A CA2524990 A CA 2524990A CA 2524990 A1 CA2524990 A1 CA 2524990A1
- Authority
- CA
- Canada
- Prior art keywords
- weight
- oral composition
- composition according
- skin
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
An oral composition is provided for improving the health of skin comprising an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
The composition may also include a phytohormone, Vitamin B, a bioflavonoid and minerals.
The composition may also include a phytohormone, Vitamin B, a bioflavonoid and minerals.
Description
ORAL SKIN SUPPLEMENT
Field of the Invention The invention relates to skin supplements for improving overall skin health.
Background of the Invention It is a well known fact that the aging process has a deleterious effect on the health and appearance of skin. This is due to the aging process itself in addition to environmental damage. Horinone change additionally contributes to aging of skin.
As women approach peri-menopause, the relative balance of three hormones, namely, estrogen, progesterone and testosterone, create significant changes in the manner in which the hydrophilic layer and the lipophilic layer of the skin behave. A
drop in estrogen decreases oil production and a drop in progesterone decreases retention of water in skin. A relative increase in testosterone can also cause acne and rosecea.
Other hormones that also play a role in skin health include growth hormone and insulin. Growth hormone is necessary for the development, healing and repair of all tissues in the body. Its production decreases after the age of 35. This results in thinner skin due to decrease collagen and elastin production. Muscle tone and mass also decrease exaggerating the appearance of saging skin.
Another hormone, insulin, is related to skin appearance. The secretion of insulin increases with age and would increase the craving and consuinption of carbohydrates.
In the skin, insulin breaks down muscle and causes general fluid retention.
This makes skin appear weak and puffy. It also causes damage to small arteries that supply the skin with oxygen and nutrients.
Biological processes in the human body and exposure to the environment, which includes sun, air pollution, toxins, cigarette smoke and pollutants, create free radicals.
Free radicals cause damage to cells via damage to DNA. This results in abnormal new tissue growth. In the skin, it causes freckles, wrinkles, moles, and in some cases, skin cancer.
Aging increases the body's inflammatory and immune responses, often exaggerating its normal response to its environment. This exaggerated response in turn causes premature damage to the body's tissues as a result of overproduction of inflammatory enzymes.
This damage is manifested in the commonly understood condition of allergies.
Allergic responses of the skin includeeczema, flushing and redness.
Previously available skin treatments to prevent or mitigate effects of aging and environmental exposure have employed topical compositions to skin. These approaches have limited success because it is very difficult to absorb nutrients required for skin health into the body through the skin. This is due to the larger size of these molecules realtive to the skin pore size.
There is, therefore, a need for a skin care composition that can be effectively absorbed into the cells of the epidermal and dermal skin layers to provide improved benefits to skin health and to combat the effects of aging and environmental damage.
Summary of the Invention The invention relates to a composition for improving the health and appearance of skin. The composition includes an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
According to one aspect of the invention, there is provided an oral composition for improving the health of skin comprising an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
According to another aspect of the invention, there is provided a method of improving the health and appearance of skin comprising orally administering to a patient a composition for improving the health of skin comprising an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
According to yet another aspect of the invention, there is provided the use of an oral composition for improving the health of skin comprising an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
Field of the Invention The invention relates to skin supplements for improving overall skin health.
Background of the Invention It is a well known fact that the aging process has a deleterious effect on the health and appearance of skin. This is due to the aging process itself in addition to environmental damage. Horinone change additionally contributes to aging of skin.
As women approach peri-menopause, the relative balance of three hormones, namely, estrogen, progesterone and testosterone, create significant changes in the manner in which the hydrophilic layer and the lipophilic layer of the skin behave. A
drop in estrogen decreases oil production and a drop in progesterone decreases retention of water in skin. A relative increase in testosterone can also cause acne and rosecea.
Other hormones that also play a role in skin health include growth hormone and insulin. Growth hormone is necessary for the development, healing and repair of all tissues in the body. Its production decreases after the age of 35. This results in thinner skin due to decrease collagen and elastin production. Muscle tone and mass also decrease exaggerating the appearance of saging skin.
Another hormone, insulin, is related to skin appearance. The secretion of insulin increases with age and would increase the craving and consuinption of carbohydrates.
In the skin, insulin breaks down muscle and causes general fluid retention.
This makes skin appear weak and puffy. It also causes damage to small arteries that supply the skin with oxygen and nutrients.
Biological processes in the human body and exposure to the environment, which includes sun, air pollution, toxins, cigarette smoke and pollutants, create free radicals.
Free radicals cause damage to cells via damage to DNA. This results in abnormal new tissue growth. In the skin, it causes freckles, wrinkles, moles, and in some cases, skin cancer.
Aging increases the body's inflammatory and immune responses, often exaggerating its normal response to its environment. This exaggerated response in turn causes premature damage to the body's tissues as a result of overproduction of inflammatory enzymes.
This damage is manifested in the commonly understood condition of allergies.
Allergic responses of the skin includeeczema, flushing and redness.
Previously available skin treatments to prevent or mitigate effects of aging and environmental exposure have employed topical compositions to skin. These approaches have limited success because it is very difficult to absorb nutrients required for skin health into the body through the skin. This is due to the larger size of these molecules realtive to the skin pore size.
There is, therefore, a need for a skin care composition that can be effectively absorbed into the cells of the epidermal and dermal skin layers to provide improved benefits to skin health and to combat the effects of aging and environmental damage.
Summary of the Invention The invention relates to a composition for improving the health and appearance of skin. The composition includes an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
According to one aspect of the invention, there is provided an oral composition for improving the health of skin comprising an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
According to another aspect of the invention, there is provided a method of improving the health and appearance of skin comprising orally administering to a patient a composition for improving the health of skin comprising an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
According to yet another aspect of the invention, there is provided the use of an oral composition for improving the health of skin comprising an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
-2-Detailed Description of the Invention The present invention is a skin health composition that is surprisingly effective in improving the health of human skin when administered orally. The skin care composition of the present invention includes an antioxidant, an essential fatty acid, an amino acid and white tea extract. Preferably, the composition also includes a phytohormone, a skin mineral, Vitamin B and a bioflavanoid.
Antioxidants Antioxidants of the present invention are also known as radical scavengers.
They protect cells from damage caused by free radicals. Antioxidants interact with and stabilize free radicals and may prevent some of the damage free radicals otherwise might cause. They have also demostrated anti-inflammatory properties. Vitamin C is required for the synthesis of collagen, an important structural component of blood vessels, tendons, ligaments, and bone.
Antioxidants within the meaning of this disclosure include beta-carotene, lycopene, vitamins C, E, and A, lipoic acid and other antioxidants known in the art.
The composition includes from about 10% to about 40% by weight of the composition of an antioxidant, preferably 15% to 35% and most preferably from 20% to 30%.
The most preferred antioxidants are Vitamin C, Vitamin E and lipoic acid.
Preferably, the composition includes a mixture of Vitamin C, Vitamin E and lipoic acid.
Preferably, the composition includes from about 15% to about 30% by weight of Vitamin C, about 1% to 10% by weight of Vitamin E and about 1% to 10% by weight of lipoic acid.
Amino acids Amino acids are the molecular units that make up proteins. All proteins are various compositions of twenty specific naturally occurring amino acids. Proteins are the building blocks of hormones and tissues.
The composition of the present invention preferably has an amino acid content of from about 20% to about 60% by weight, more preferably from about 25% to about
Antioxidants Antioxidants of the present invention are also known as radical scavengers.
They protect cells from damage caused by free radicals. Antioxidants interact with and stabilize free radicals and may prevent some of the damage free radicals otherwise might cause. They have also demostrated anti-inflammatory properties. Vitamin C is required for the synthesis of collagen, an important structural component of blood vessels, tendons, ligaments, and bone.
Antioxidants within the meaning of this disclosure include beta-carotene, lycopene, vitamins C, E, and A, lipoic acid and other antioxidants known in the art.
The composition includes from about 10% to about 40% by weight of the composition of an antioxidant, preferably 15% to 35% and most preferably from 20% to 30%.
The most preferred antioxidants are Vitamin C, Vitamin E and lipoic acid.
Preferably, the composition includes a mixture of Vitamin C, Vitamin E and lipoic acid.
Preferably, the composition includes from about 15% to about 30% by weight of Vitamin C, about 1% to 10% by weight of Vitamin E and about 1% to 10% by weight of lipoic acid.
Amino acids Amino acids are the molecular units that make up proteins. All proteins are various compositions of twenty specific naturally occurring amino acids. Proteins are the building blocks of hormones and tissues.
The composition of the present invention preferably has an amino acid content of from about 20% to about 60% by weight, more preferably from about 25% to about
-3-55% and most preferably from about 35% to about 45%. The preferred amino acids for the purposes of the present invention are lysine and arginine. Preferably, the composition includes about equal amounts of arginine and lysine. Preferably, this amount is about 21 % by weight of the composition of each of lysine and arginine.
Essential Fatty Acids Essential fatty acids are those fatty acids that humans cannot synthesize, and must be obtained through diet. They are long-chain polyunsaturated fatty acids derived from linolenic, linoleic, and oleic acids. Essential fatty acids are necessary for the formation of healthy cell membranes, the proper development and functioning of the brain and nervous system, and for the production of hormone-like substances called eicosanoids (thromboxanes, leukotrienes, prostaglandins). These chemicals regulate numerous body functions including blood pressure, blood viscosity, vasoconstriction, immune and inflammatory responses. Humans have the ability to convert the linoleic and alpha-linolenic acid to longer chain fatty acids, which serve as precursors for eicosanoids. Omega-3 fatty acids and omega-6 fatty acids are essential fatty acids. Key omega-3 fatty acids include eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA), both found primarily in oily cold-water fish such as tuna, salmon, and mackerel.
The present composition includes about 1% to about 10% by weight of an essential fatty acid. More preferably from about 2% to about 6%. Most preferably the composition includes about 4% by weight of an essential fatty acid.
The present composition preferably includes a source of DHA. Most preferably the DHA is derived from a powder known commercially as neuromins. 600mg of the neuromins powder provides about 78mg of DHA.
The composition of the present invention can also include various combinations of essential fatty acids.
White Tea Extract The composition includes white tea extract. White tea is a rare tea from the same plant (Camellia sinensis) as green and black teas. White tea is the least processed of all teas,
Essential Fatty Acids Essential fatty acids are those fatty acids that humans cannot synthesize, and must be obtained through diet. They are long-chain polyunsaturated fatty acids derived from linolenic, linoleic, and oleic acids. Essential fatty acids are necessary for the formation of healthy cell membranes, the proper development and functioning of the brain and nervous system, and for the production of hormone-like substances called eicosanoids (thromboxanes, leukotrienes, prostaglandins). These chemicals regulate numerous body functions including blood pressure, blood viscosity, vasoconstriction, immune and inflammatory responses. Humans have the ability to convert the linoleic and alpha-linolenic acid to longer chain fatty acids, which serve as precursors for eicosanoids. Omega-3 fatty acids and omega-6 fatty acids are essential fatty acids. Key omega-3 fatty acids include eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA), both found primarily in oily cold-water fish such as tuna, salmon, and mackerel.
The present composition includes about 1% to about 10% by weight of an essential fatty acid. More preferably from about 2% to about 6%. Most preferably the composition includes about 4% by weight of an essential fatty acid.
The present composition preferably includes a source of DHA. Most preferably the DHA is derived from a powder known commercially as neuromins. 600mg of the neuromins powder provides about 78mg of DHA.
The composition of the present invention can also include various combinations of essential fatty acids.
White Tea Extract The composition includes white tea extract. White tea is a rare tea from the same plant (Camellia sinensis) as green and black teas. White tea is the least processed of all teas,
-4-as it is picked then rapidly steamed and dried rather than fermented or roasted. White tea's primary benefit is as an antioxidant, squelching free radicals. White tea extract delivers anti-skin cancer properties and boosts cell immunity against skin aging.
Preferably, white tea extract is included in the composition in an amount of from about 5% to about 15% of the composition. Most preferably the white tea extract content is about 10% by weight of the composition.
Phytohormones The composition preferably includes a phytohormone. Phytohormones function to coordinate plant growth and development. Compounds that are considered to be phytohormones for the purposes of the present invention include, indole-3-acetic acid (auxin), cytokinin, gibberellin, ethylene, abscisic acid, brassinosteroids, jasmonic acid, salicylic acid, flavonoids, carbohydrates, fatty acids, peptides and phenolic acids and alcohols.
The present composition includes about 1% to about 10% by weight of the composition of a phytohormone. More preferably from about 2% to about 6%. Most preferably, the composition includes about 3% by weight of the composition of a phytohormone.
Preferably, the phytohormone is a soy isoflavone. The composition may also include various combinations of phytohormones.
Bioflavanoids The composition preferably includes a bioflavanoid that acts as a vasoconstrictor to help decrease redness and/or flushing. The bioflavanoid is preferably present in an amount from about 2% to about 6% by weight of the composition. Most preferably, the composition includes about 4% by weight of the bioflavanoid. The preferred bioflavanoids for the purposes of the present invention are hesperidin and grape seed extract. For grape seed extract, the preferred content is about 1% to about 3%
by weight of the composition. Most preferably, the composition includes about 1.5% by weight of the grape seed extract.
Preferably, white tea extract is included in the composition in an amount of from about 5% to about 15% of the composition. Most preferably the white tea extract content is about 10% by weight of the composition.
Phytohormones The composition preferably includes a phytohormone. Phytohormones function to coordinate plant growth and development. Compounds that are considered to be phytohormones for the purposes of the present invention include, indole-3-acetic acid (auxin), cytokinin, gibberellin, ethylene, abscisic acid, brassinosteroids, jasmonic acid, salicylic acid, flavonoids, carbohydrates, fatty acids, peptides and phenolic acids and alcohols.
The present composition includes about 1% to about 10% by weight of the composition of a phytohormone. More preferably from about 2% to about 6%. Most preferably, the composition includes about 3% by weight of the composition of a phytohormone.
Preferably, the phytohormone is a soy isoflavone. The composition may also include various combinations of phytohormones.
Bioflavanoids The composition preferably includes a bioflavanoid that acts as a vasoconstrictor to help decrease redness and/or flushing. The bioflavanoid is preferably present in an amount from about 2% to about 6% by weight of the composition. Most preferably, the composition includes about 4% by weight of the bioflavanoid. The preferred bioflavanoids for the purposes of the present invention are hesperidin and grape seed extract. For grape seed extract, the preferred content is about 1% to about 3%
by weight of the composition. Most preferably, the composition includes about 1.5% by weight of the grape seed extract.
-5-Other Ingredients The composition may include other ingredients such as Vitamin B. The preferred form of Vitamin B is Vitamin B3, also known as niacinamide. Niacinamide is preferably present in an amount of about 3% to 10% by weight of the composition.
Most preferably, it is present in an amount of about 5% by weight of the composition.
The composition also preferably includes minerals such as calcium and zinc in an amount of about 1% by weight of the composition.
Delivery Vehicles The composition is administered orally. Tablets containing various excipients such as sodium citrate, calcium carbonate and dicalcium phosphate may be employed along with various disintegrants such as starch and preferably potato or tapioca, starch, alginic acid and certain complex silicates, together with binding agents such as polyvinylpyrrolidone, gelatin and acacia. Additionally, lubricating agents such as magnesium stearate, sodium lauryl sulfate and talc are often very useful for tabletting purposes. Preferably the composition is delivered orally via a gelatine capsule.
Similar excipients may also be used as fillers in soft and hard-filled gelatin capsules.
The excipients may also include the high molecular weight polyethylene glycols.
Other preferred excipients include: anhydrous lactose, low moisture microcrystalline cellulose, and anhydrous calcium phosphate dibasic and other suitable low moisture or anhydrous diluents.
Compositions The following compositions set out in Tables I and II are preferred compositions of the present invention.
Table I: Composition A
COMPOUND AMOUNT (mg/4 capsules) Vitamin C 500
Most preferably, it is present in an amount of about 5% by weight of the composition.
The composition also preferably includes minerals such as calcium and zinc in an amount of about 1% by weight of the composition.
Delivery Vehicles The composition is administered orally. Tablets containing various excipients such as sodium citrate, calcium carbonate and dicalcium phosphate may be employed along with various disintegrants such as starch and preferably potato or tapioca, starch, alginic acid and certain complex silicates, together with binding agents such as polyvinylpyrrolidone, gelatin and acacia. Additionally, lubricating agents such as magnesium stearate, sodium lauryl sulfate and talc are often very useful for tabletting purposes. Preferably the composition is delivered orally via a gelatine capsule.
Similar excipients may also be used as fillers in soft and hard-filled gelatin capsules.
The excipients may also include the high molecular weight polyethylene glycols.
Other preferred excipients include: anhydrous lactose, low moisture microcrystalline cellulose, and anhydrous calcium phosphate dibasic and other suitable low moisture or anhydrous diluents.
Compositions The following compositions set out in Tables I and II are preferred compositions of the present invention.
Table I: Composition A
COMPOUND AMOUNT (mg/4 capsules) Vitamin C 500
-6-Vitamin E 266.67 Lipoic Acid 100 White Tea Extract 200 L-Lysine 500 L-Arginine 500 Soy Isoflavones 50 DHA 6.5 Zinc Citrate 25 Table II: Composition B
COMPOUND AMOUNT (m /g 4 capsules) Vitamin C (Ester C) 250 Vitamin C (Ascorbyl Palmitate) 150 Vitamin E (d-alpha tocopherol) 66.67 Lipoic Acid 50 White Tea Extract 200 Grape Seed Extract 30 L-Lysine 400 L-Arginine 400 Soy Isoflavones 50
COMPOUND AMOUNT (m /g 4 capsules) Vitamin C (Ester C) 250 Vitamin C (Ascorbyl Palmitate) 150 Vitamin E (d-alpha tocopherol) 66.67 Lipoic Acid 50 White Tea Extract 200 Grape Seed Extract 30 L-Lysine 400 L-Arginine 400 Soy Isoflavones 50
-7-Niacinamide 100 Zinc Citrate 25 Hesperidin 80 Examples Example I
Patient A, a teenager with active acne had been treated over a three month period with topical treatments including skin care products and topical prescription medications.
Topical treatments were inadequate in resolving active breakouts of pimples and the formation of cystic acne. The addition of oral supplementation that included antioxidants, essential amino acids and fatty acids dramatically improved the overall recovery and health of acne prone skin.
Example 2 Patient B, a menopausal patient recently off hormone replacement therapy complained of dryness of the skin and acne breakouts after receiving topical skin care treatment.
With the addition of oral supplments that included antioxidants, essential amino acids and essential fatty acids and phytohormones, the patient noted dramatically improved moisture and a decrease of flushing and breakouts of the skin.
Example 3 Patient C, an atopic patient with allergy history was unable to keep eczema under control with topical creams including skin moisturizers and steroid medication. With the addition of oral supplements that included antioxidants, essential amino acids and essential fatty acids, the patient noted a decrease and improvement in eczema.
Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the embodiments of the invention
Patient A, a teenager with active acne had been treated over a three month period with topical treatments including skin care products and topical prescription medications.
Topical treatments were inadequate in resolving active breakouts of pimples and the formation of cystic acne. The addition of oral supplementation that included antioxidants, essential amino acids and fatty acids dramatically improved the overall recovery and health of acne prone skin.
Example 2 Patient B, a menopausal patient recently off hormone replacement therapy complained of dryness of the skin and acne breakouts after receiving topical skin care treatment.
With the addition of oral supplments that included antioxidants, essential amino acids and essential fatty acids and phytohormones, the patient noted dramatically improved moisture and a decrease of flushing and breakouts of the skin.
Example 3 Patient C, an atopic patient with allergy history was unable to keep eczema under control with topical creams including skin moisturizers and steroid medication. With the addition of oral supplements that included antioxidants, essential amino acids and essential fatty acids, the patient noted a decrease and improvement in eczema.
Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the embodiments of the invention
-8-described specifically above. Such equivalents are intended to be encompassed in the scope of the following claims.
Various embodiments of the present invention having been thus described in detail by way of example, it will be apparent to those skilled in the art that variations and modifications may be made without departing from the invention. The invention includes all such variations and modifications as fall within the scope of the appended claims.
Various embodiments of the present invention having been thus described in detail by way of example, it will be apparent to those skilled in the art that variations and modifications may be made without departing from the invention. The invention includes all such variations and modifications as fall within the scope of the appended claims.
-9-
Claims (24)
1. An oral composition for improving the health of skin comprising an antioxidant, an essential fatty acid, an amino acid, and white tea extract.
2. An oral composition according to claim 1 wherein the antioxidant is selected from the group consisting of Vitamin C, Vitamin E, lipoic acid and mixtures thereof.
3. An oral composition according to claim 1 or claim 2 wherein the essential fatty acid is docohexaenoic acid (DHA).
4. An oral composition according to any one of claims 1-3 wherein the amino acid is arginine, lysine or mixtures thereof.
5. An oral composition according to any one of claims 1-4 wherein the composition further comprises a phytohormone.
6. An oral composition according to claim 5 wherein the phytohormone is a soy isoflavone.
7.An oral composition according to any one of claims 1-6 further comprising zinc citrate.
8. An oral composition comprising according to claim 1 comprising about 10%
to about 40% by weight of the antioxidant, about 1% to about 10% by weight of the essential fatty acid, about 20% to about 60% by weight of the amino acid, and about 5% to about 15% by weight of the white tea extract.
to about 40% by weight of the antioxidant, about 1% to about 10% by weight of the essential fatty acid, about 20% to about 60% by weight of the amino acid, and about 5% to about 15% by weight of the white tea extract.
9. An oral composition according to claim 8 further comprising from about 1%
to about 10% by weight of the composition of a phytohormone.
to about 10% by weight of the composition of a phytohormone.
10. An oral composition according to claim 8 or claim 9 further comprising from about 1% to about 3% by weight of the composition of zinc citrate.
11. An oral composition according to any one of claims 1-10 wherein the composition comprises about 21% by weight of Vitamin C, about 4% by weight of Vitamin E and about 3% by weight of lipoic acid.
12. An oral composition according to any one of claims 1-11 wherein the composition comprises about 21% by weight of arginine and about 21% by weight of lysine.
13.An oral composition according to any one of claims 1-12 wherein the composition comprises about 11% by weight of the white tea extract.
14. An oral composition according to any one of claims 1-13 wherein the composition comprises about 2% to 6% by weight of DHA.
15. An oral composition according to any one of claims 1-14 wherein the composition comprises about 1% to about 5% by weight of soy isoflavones.
16. An oral composition according to claim 1 further comprising niacinamide.
17.An oral composition according to claim 1 or 16 further comprising grape seed extract.
18. An oral composition according to claim 1, 16 or 17 further comprising hesperin.
19. An oral composition according to claim 1, 16, 17 or 18 further comprising a bioflavanoid.
20. An oral composition according to claim 19 wherein the bioflavanoid is hesperin.
21. An oral composition according to claim 2 wherein the content of Vitamin C
is 15% to about 30% by weight of the composition, the content of Vitamin E is about 1% to 10% by weight of the composition and the content of lipoic acid is about 1% to 10% by weight of the composition.
is 15% to about 30% by weight of the composition, the content of Vitamin E is about 1% to 10% by weight of the composition and the content of lipoic acid is about 1% to 10% by weight of the composition.
22. An oral composition according to any one of claims 1-21 wherein the oral composition is in the form of a capsule.
23. An oral composition according to claim 22 wherein the capsule is a gel capsule.
24. Use of an oral composition according to any one of claims 1-23 for improving the quality of skin in a human.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002524990A CA2524990A1 (en) | 2005-10-31 | 2005-10-31 | Oral skin supplement |
PCT/CA2006/001791 WO2007051297A1 (en) | 2005-10-31 | 2006-10-31 | Oral skin supplement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002524990A CA2524990A1 (en) | 2005-10-31 | 2005-10-31 | Oral skin supplement |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2524990A1 true CA2524990A1 (en) | 2007-04-30 |
Family
ID=38005387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002524990A Abandoned CA2524990A1 (en) | 2005-10-31 | 2005-10-31 | Oral skin supplement |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA2524990A1 (en) |
WO (1) | WO2007051297A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007052536A1 (en) * | 2007-11-01 | 2009-05-07 | Beiersdorf Ag | Active substance combinations of aniseed fruit extract and white tea extract |
WO2010025335A2 (en) * | 2008-08-29 | 2010-03-04 | Dr Pepper/Seven Up, Inc. | Functional consumable compositions for promoting skin health and methods for using the same |
FR2981272A1 (en) * | 2011-10-14 | 2013-04-19 | Inneov Lab | USE OF AN ORAL COMPOSITION COMPRISING A MIXTURE OF AT LEAST ONE POLYPHENOL, ZINC, AND VITAMIN C. |
FR3001633B1 (en) * | 2013-02-04 | 2017-02-24 | Laboratoires Inneov | COSMETIC COMBINATION OF NUTRITIONAL ASSETS TO MAINTAIN A GOOD STATE OF THE SKIN AND TO PROMOTE LOSS OF WEIGHT |
JP7321632B2 (en) * | 2018-05-28 | 2023-08-07 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Composition for prevention or treatment of oral disease |
GB201811312D0 (en) * | 2018-07-10 | 2018-08-29 | Nuchido Ltd | Compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080026663A (en) * | 2000-05-12 | 2008-03-25 | 벵트 크리스터 올손 | Compositions for Oral Administration |
CN101026965A (en) * | 2004-06-25 | 2007-08-29 | 费诺森股份有限公司 | Compositions suitable for treating cutaneous signs of aging |
-
2005
- 2005-10-31 CA CA002524990A patent/CA2524990A1/en not_active Abandoned
-
2006
- 2006-10-31 WO PCT/CA2006/001791 patent/WO2007051297A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007051297A1 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
He et al. | Research progress on the health function of tea oil | |
AU2007254653B2 (en) | Skin rejuvenation cream | |
JP2010132639A (en) | Dna damage inhibitor and matrix metalloprotease-1 production inhibitor | |
WO2007051297A1 (en) | Oral skin supplement | |
RU2009126740A (en) | NUTRITION SUPPLEMENT COMPOSITION FOR THE TREATMENT OF EYE DISEASES | |
EP1667699A1 (en) | Lotus and methyl donors | |
WO2007004229A2 (en) | Methods of using pomegranate fractions for skin repair | |
CN104814908A (en) | Mask with effects of resisting wrinkle and tendering skin | |
CN103381136B (en) | A kind of edible cosmetics and preparation method thereof | |
KR102086687B1 (en) | A yellow cosmetic composition for improving skin wrinkles comprising an active ingredient of a plant complex extract | |
CN105377226B (en) | The purposes of aesthetic obstacle of the petroselic acid to fight body build | |
CN103919710B (en) | A kind of improving water flood facial mask and its preparation method | |
Ghode et al. | Formulation And Evaluation Of Facial Scrub Containing Sunflower Seeds And Other Natural Ingredients | |
CA2885679A1 (en) | Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound | |
TWI580438B (en) | Contains a composition of polyunsaturated fatty acids | |
CN102362843B (en) | Tea seed oil skin oil and preparation method thereof | |
RU2445111C1 (en) | Method for making pumpkin seed oil used for therapeutic, food and cosmetic purposes, and biologically active agent | |
ES2505252T3 (en) | Annatto extract compositions that include tocotrienols and tocopherols and methods of use | |
JP2005263655A (en) | Antioxidant | |
EP3991801A1 (en) | Composition for improving skin condition containing plant extracts | |
Alalwan | Nutraceuticals and their role in promoting musculoskeletal healthy aging. | |
Rawung et al. | Cookies rich in antioxidant from mango (Mangifera indica) with binahong (Anredera cordifolia) as a potential for postoperative wound healing | |
KR100563673B1 (en) | Health functional foods to improve skin wrinkles and suppress skin wrinkles | |
CN104664401A (en) | Soy isoflavone vitamin E soft capsule | |
JPH11322628A (en) | External preparation for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |